Evidence map›Paper›PMID 41551419›Full record

ArticleInternational journal of mental health and addiction2025

Mental Health Care for Patients with Opioid Use Disorder and Methamphetamine Use in Methadone Maintenance Treatment: Experiences and Perspectives.

Huyen Pham, Chunqing Lin, Diep Bich Nguyen, Larissa J Mooney, Giang Minh Le, Steven J Shoptaw, Hai Van Truong, Yih-Ing Hser

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of mental health and addiction, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Huyen PhamDepartment of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, 10911 Weyburn Avenue, Suite 200, Los Angeles, CA 90024, USA.
Chunqing LinDepartment of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, 10911 Weyburn Avenue, Suite 200, Los Angeles, CA 90024, USA.
Diep Bich NguyenSchool of Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Vietnam.
Larissa J MooneyDepartment of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, 10911 Weyburn Avenue, Suite 200, Los Angeles, CA 90024, USA.
Giang Minh LeSchool of Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Vietnam.
Steven J ShoptawDepartment of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, 10911 Weyburn Avenue, Suite 200, Los Angeles, CA 90024, USA.
Hai Van TruongSchool of Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Vietnam.
Yih-Ing HserDepartment of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, 10911 Weyburn Avenue, Suite 200, Los Angeles, CA 90024, USA.ORCID 0000-0002-5809-739X

Funding

UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI RAPHAEL J LANDOVITZ · 1997 to 2026
$53.5M
Greater Southern California Node of the Clinical Trials NetworkUG1DA049435 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YIH-ING HSER · 2019 to 2026
$16.7M
NIDA NIH HHS UG1 DA049435NIMH NIH HHS P30 MH058107
6 · The paper itself

Abstract

Untreated co-occurring mental health disorders (MHD) and substance use disorders (SUD) are associated with negative treatment outcomes. This study explored the experiences and perspectives of patients with opioid use disorder (OUD) who were using methamphetamine while undergoing methadone maintenance treatment (MMT) regarding barriers and facilitators to accessing MHD services. We conducted 30 in-depth interviews with MMT participants with varying levels of MHD severity, assessed using the 21-item Depression, Anxiety, Stress Scale (DASS-21). Barriers to seeking MHD services included lack of awareness, fear of additional stigma and extra burden to families, unaddressed poly-substance use, and lack of specialized professionals. Benefits of integrating MHD services into MMT clinics included improved diagnosis, streamlined referrals, and reduced logistical challenges. Key facilitators identified included supportive family members, healthcare professionals, and digital platforms. Integrating MHD care into MMT, emphasizing family involvement, staff training, and digital platforms, holds promise to improve MHD diagnosis, referral, and treatment.

Indexed as

Integrated careMethadone maintenance treatmentPsychiatric comorbiditySubstance use disordersVietnam

Identifiers

PMID41551419
PMCPMC12811026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.